GERI-BP002-A, novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus F93.
Y K Kim, H W Lee, K H Son, B M Kwon, T S Jeong, D H Lee, J Shin, Y Seo, S U Kim, S H Bok
Index: J. Antibiot. 49(1) , 31-6, (1996)
Full Text: HTML
Abstract
A new inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), designated GERI-BP002-A, was isolated from the culture broth of Aspergillus fumigatus F93 by acetone extraction, EtOAc extraction, SiO2 column chromatography and reverse phase HPLC. Spectroscopic analyses of the compound identified bis (2-hydroxy-3-tert-butyl-5-methylphenyl) methane as the structure and its molecular weight and formula to be 340 and C23H32O2, respectively. GERI-BP002-A inhibited ACAT activity by 50% at the concentration of 50 microM in an enzyme assay system using rat liver microsomes.
Related Compounds
Related Articles:
2012-08-03
[Biochem. Biophys. Res. Commun. 424(3) , 616-9, (2012)]
Effects of four bisphenolic antioxidants on lipid contents of rat liver.
1981-04-01
[Toxicol. Lett. 8(1-2) , 77-86, (1981)]
1993-05-01
[Biochem. Soc. Trans. 21(2) , 106S, (1993)]
1994-05-01
[J. Toxicol. Sci. 19(2) , 77-88, (1994)]
[Studies on the teratogenic potential of 2,2'-methylenebis (4-methyl-6-tert-butylphenol) in rats].
1990-01-01
[Eisei Shikenjo Hokoku. (108) , 52-7, (1990)]